Gut Microbiota Modulation by Selenium and Zinc Enrichment Postbiotic on Dysbiosis Associated with Hypertension
- PMID: 38779729
- DOI: 10.2174/0115701611290537240509061549
Gut Microbiota Modulation by Selenium and Zinc Enrichment Postbiotic on Dysbiosis Associated with Hypertension
Abstract
Background: Targeting gut dysbiosis to treat chronic diseases or to alleviate the symptoms is a new direction for medical adjuvant therapies. Recently, postbiotics have received considerable attention as they are non-viable probiotic preparations that confer various health benefits to the host without the safety problems associated with using live microbial cells.
Objective: The aim of the study is to obtain selenium (Se) and zinc (Zn) enriched Saccharomyces boulardii postbiotic biomass and to analyze its modulation effect because these minerals play an important role in reducing gut dysbiosis linked to cardiovascular (CV) diseases.
Method: The effect of the S. boulardii and Se/Zn enriched yeast postbiotics on CV microbial fingerprint was studied in vitro using the gastrointestinal system (GIS 1) and analyzed by microbiological, chemical, and qPCR methods.
Result: There was a 2.2 log CFU/mL increase in the total bacterial load after SeZn postbiotic treatment and in the qPCR counts of Firmicutes phyla for both treatments. Beneficial taxa, Bifidobacterium spp. and Lactobacillus spp., as well as Bacteroidesspp. were up to 1.5 log higher after mineral- enriched postbiotic application, while the acetic acid level increased.
Conclusion: These preliminary studies highlight the therapeutic potential of using Se/Zn enriched yeast postbiotics as adjuvants for clinical treatments of CV diseases.
Keywords: Saccharomyces boulardii; cardiovascular disease treatment.; gut microbiota modulation; hypertension associated dysbiosis; in vitro gastrointestinal simulation; postbiotic; selenium and zinc enriched biomass.
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.
Similar articles
-
Mineral-Enriched Postbiotics: A New Perspective for Microbial Therapy to Prevent and Treat Gut Dysbiosis.Biomedicines. 2022 Sep 25;10(10):2392. doi: 10.3390/biomedicines10102392. Biomedicines. 2022. PMID: 36289654 Free PMC article. Review.
-
Saccharomyces boulardii ameliorates gut dysbiosis associated cognitive decline.Physiol Behav. 2021 Jul 1;236:113411. doi: 10.1016/j.physbeh.2021.113411. Epub 2021 Mar 31. Physiol Behav. 2021. PMID: 33811908
-
The Modulation Effect of a Fermented Bee Pollen Postbiotic on Cardiovascular Microbiota and Therapeutic Perspectives.Biomedicines. 2023 Oct 5;11(10):2712. doi: 10.3390/biomedicines11102712. Biomedicines. 2023. PMID: 37893086 Free PMC article.
-
Lacticaseibacillus rhamnosus GG and Saccharomyces cerevisiae boulardii supplementation exert protective effects on human gut microbiome following antibiotic administration in vitro.Benef Microbes. 2021 Aug 30;12(4):59-73. doi: 10.3920/BM2020.0180. Epub 2021 Jun 30. Benef Microbes. 2021. PMID: 34190033
-
Application of Microbiome-Based Therapies in Chronic Respiratory Diseases.J Microbiol. 2024 Mar;62(3):201-216. doi: 10.1007/s12275-024-00124-1. Epub 2024 Apr 18. J Microbiol. 2024. PMID: 38635003 Review.
References
-
- World Health Organization. Fact sheets. Available from: https://www.who.int/news-room/fact-sheets/detail/
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous